CEO of a startup tries out treatments to stop aging

Elizabeth Parrish, the 44-year-old head of BioViva, a biotechnology startup, said she started gene therapy on herself last month in an undisclosed location: the goal is to directly test solutions that will become cures for Alzheimer's and muscle loss. Parrish said in an online interview Sunday that she underwent two forms of gene therapy after contracting with a lab… Read more